Medplus Health Services Ltd Share Price – NSE  / BSE

Retail, Small Cap

MedPlus Health Services has allotted 1,46,675 equity shares under ESOP on 18 December 2024. With this allotment, the paid up equity share capital has increased to 11,96,93,831 equity shares of each aggregating to Rs. 23,93,87,662.

Powered by Capital Market - Live News

Profit before tax soared 190.63% year on year (YoY) to Rs 47.78 in the quarter ended 30 September 2024.

Operating EBITDA stood at 73.9 crore in September 2024 quarter, up 80.24% from Rs 41 crore reported in Q2 FY24. Operating EBITDA margin improved to 4.7% in Q2 FY25 as compared to 2.9% recorded in the corresponding period last year.

Gross margin increased to 23.7% in second quarter of FY25 as against 21.6% posted in similar period previous fiscal.

The pharmaco added 108 stores during the quarter taking the total to 4,552 stores, as on September 2024.

Medplus Health Services is in the business of pathological laboratory testing and manufacturing, wholesale trading and contract manufacturing of pharma, fast-moving consumer goods and beauty products and rendering of management services to group companies and holds investments in subsidiary companies.

Powered by Capital Market - Live News

Net profit of Medplus Health Services rose 166.07% to Rs 38.74 crore in the quarter ended September 2024 as against Rs 14.56 crore during the previous quarter ended September 2023. Sales rose 11.90% to Rs 1576.17 crore in the quarter ended September 2024 as against Rs 1408.59 crore during the previous quarter ended September 2023.

Powered by Capital Market - Live News

Medplus Health Services will hold a meeting of the Board of Directors of the Company on 12 November 2024.

Powered by Capital Market - Live News